Form 8-K - Current report:
SEC Accession No. 0001638287-18-000008
Filing Date
2018-03-15
Accepted
2018-03-15 16:03:48
Documents
3
Period of Report
2018-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gemp-20180315x8k.htm 8-K 38044
2 EX-99.1 gemp-20180315ex9910d228f.htm EX-99.1 183267
3 GRAPHIC gemp20180315ex9910d228f001.jpg GRAPHIC 4840
  Complete submission text file 0001638287-18-000008.txt   229301
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37809 | Film No.: 18692380
SIC: 2834 Pharmaceutical Preparations